An Indian court on Monday rejected a challenge to the country's patent laws by Swiss pharmaceutical giant Novartis, a decision hailed by medical aid groups as a victory for millions of poor patients in developing countries. Novartis said the court ruling -- over the definition of a new or improved drug -- was a blow to the idea of intellectual property rights and would have long-term negative effects on research into new drugs. However, the company said it was unlikely to appeal the ruling.
August 06, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
An Indian court on Monday rejected a challenge to the country’s patent laws by Swiss pharmaceutical giant Novartis, a decision hailed by medical aid groups as a victory for millions of poor patients in developing countries.
Novartis said the court ruling — over the definition of a new or improved drug — was a blow to the idea of intellectual property rights and would have long-term negative effects on research into new drugs. However, the company said it was unlikely to appeal the ruling.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
AMENDED NOTICE OF BANKRUPTCY JUDGE VACANCIES DISTRICT OF UTAH The United States Court of Appeals for the Tenth Circuit seeks applicati...
The New Jersey State Commission of Investigation (SCI) is seeking an experienced and visionary leader to serve as its next Executive Directo...
We are a boutique firm specializing the area of real estate law and handling both litigation and transactional matters. We are seeking an as...
